Vancomycin Is Not an Effective Prophylactic Agent Alone and Should Be Combined With Another Agent
Saved in:
| Main Authors: | Stephen Duncan, MD, Ryland Kagan, MD |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-12-01
|
| Series: | Arthroplasty Today |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2352344124002632 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Prophylactic routine posterior pericardiotomy: Should we perform it in every patient?Central Message
by: Vasily I. Kaleda, MD, et al.
Published: (2022-08-01) -
Prophylactic Vancomycin Drops Reduce the Severity of Early Bacterial Keratitis in Keratoprosthesis.
by: Aris Konstantopoulos, et al.
Published: (2015-01-01) -
Steroids and/or Cytotoxic Agents Should Be Used Early in the Management of Patients with IPF -- The Con Argument
by: Stephen K Field
Published: (2004-01-01) -
Aspirin for Venous Thromboembolism Prophylaxis and Nonsteroidal Anti-inflammatory Agents Should Be Administered at Least 2 Hours Apart
by: Matthew J. Grosso, MD
Published: (2025-04-01) -
Can robots be responsible moral agents? And why should we care?
by: Amanda Sharkey
Published: (2017-07-01)